somatoprim
Small moleculeexperimental
Clinical trial activity
5 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2008 (NCT02217488)
Timeline
Indications
Mechanism of action
- Somatostatin receptorAGONIST
Somatostatin receptor agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dg3173
- dg3173
- dg3173
- ptr 3173
- ptr-3173
- somatoprim
- somatoprim
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02217826 | Phase 1 | Aug 14, 2014 | Aspireo Pharmaceuticals Limited |
| NCT02217800 | Phase 2 | Jan 1, 2014 | Aspireo Pharmaceuticals Limited |
| NCT02235987 | Phase 2 | Oct 1, 2012 | Aspireo Pharmaceuticals Limited |
| NCT02217839 | Phase 1 | Apr 1, 2012 | Aspireo Pharmaceuticals Limited |
| NCT02217488 | Phase 1 | May 1, 2008 | Aspireo Pharmaceuticals Limited, DeveloGen AG, Germany |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aspireo Pharmaceuticals Limited | For profit | 5 | 5 | 2 | 2008 |
| DeveloGen AG, Germany | For profit | 1 | 0 | 1 | 2008 |
2 organizations
Page 1 / 1